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Aim
The aim of the study was to evaluate the immunogenicity
of hepatitis B vaccine after primary immunization in chil-
dren vertically infected with HCV.
Patients and methods
105 infants born to HCV infected mothers were vacci-
nated against hepatitis B virus (recombinant vaccine, 10
μg, 0-1-6 month schedule). The diagnosis of HCV infec-
tion in infants was based on positive viral RNA in serum
by PCR (Amplicor v 2,0 Roche) on at least two separate
speciments in the first year of life. HCV infection was con-
firmed in 18 children. 87 children who were HCV unin-
fected formed the control group. Anti-HBs titers were
measured 3-6 months after the third dose of immuniza-
tion in HCV infected children and in control group. Sero-
conversion was considered if anti-HBs level was ≥ 10
mIU/mL. Non-responders were tested for HBV infection
by PCR.
Results
13/18 (73%) HCV infected children achieved seroconver-
sion (anti-HBs ≥10 mIU/l) compared to 80/87 (92%) in
the control group. 5 (27%) HCV infected children and 7
(8%) healthy subjects were non-responders (p=0,04).
Antibody titers ≥ 100 IU/l following vaccination were
observed in 10/18 (55%) HCV infected and in 56/87
(64%) uninfected children. The mean level of anti-HBs in
hepatitis C infected children was lower than that found in
control group (180 mIU/ml and 306 mIU/ml respec-
tively). None of non-responders were infected with HBV.
Conclusions
The immunogenicity of HBV vaccine seems to be lower in
infants infected with HCV. Further studies are necessary to
establish the role of cellular response and immune mem-
ory in protection of HCV-infected individuals without
anti-HBs antibodies after vaccination.
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